AVEO PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aveo Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 34.6M shares, a 0.72% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 34.6M +247K +0.72% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 34.6M +240K +0.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 34.5M +34.2M +13835% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 34.5M +7.59M +28.2% Dec 31, 2021 10-Q 2022-11-07
Q3 2021 34.4M +8.57M +33.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 34.4M +8.57M +33.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 247K -26.6M -99.1% Mar 31, 2021 10-K 2022-03-14
Q4 2020 26.9M +10.8M +67.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 25.8M -135M -83.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 25.8M -135M -83.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 26.9M -112M -80.7% Mar 31, 2020 10-K 2021-03-16
Q4 2019 16.1M +3.43M +27.1% Dec 31, 2019 10-K 2021-03-16
Q3 2019 161M +39.2M +32.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 161M +41.7M +35.1% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 139M +20.1M +16.9% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 12.6M -106M -89.3% Dec 31, 2018 10-K 2020-03-16
Q3 2018 122M +3.22M +2.72% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 119M +2.16M +1.85% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 119M +8.5M +7.71% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 118M +42.5M +56% Dec 31, 2017 10-K 2019-03-14
Q3 2017 118M +42.5M +56% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 117M +41M +54% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 110M +52.2M +89.7% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 75.9M +17.7M +30.4% Dec 31, 2016 10-K 2018-03-13
Q3 2016 75.9M +17.7M +30.4% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 75.9M +20.1M +36.2% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 58.2M +3.17M +5.77% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 58.2M +5.89M +11.3% Dec 31, 2015 10-K 2017-03-22
Q3 2015 58.2M +5.93M +11.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 55.7M +3.41M +6.53% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 55M +2.75M +5.25% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 52.3M +480K +0.93% Dec 31, 2014 10-K 2016-03-15
Q3 2014 52.2M +30K +0.06% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 52.3M +85K +0.16% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 52.3M +414K +0.8% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 51.8M +8.03M +18.3% Dec 31, 2013 10-K 2015-03-06
Q3 2013 52.2M +8.48M +19.4% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 52.2M +8.58M +19.7% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 51.8M +8.29M +19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 43.8M +526K +1.22% Dec 31, 2012 10-K 2014-03-13
Q3 2012 43.7M +550K +1.27% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 43.6M +741K +1.73% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 43.6M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 43.3M +7.65M +21.5% Dec 31, 2011 10-K 2013-03-11
Q3 2011 43.2M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 42.9M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 35.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.